BCNephro Logo

Kidney Disease

Home|Kidney Disease

Lipid Lowering Agents and the Kidney

Many, if not most patients with chronic kidney disease (CKD) will have indications and benefit from pharmacologic treatment of hyperlipidemia.  Despite this patients and some clinicians may have concerns about nephrotoxicity with use of these medications. This article will review the data regarding renal safety and the potential for adverse renal effects of

By |2024-10-31T12:56:58+00:00October 31st, 2024|Kidney Disease|0 Comments

Alport Syndrome

Alport syndrome is the most common inherited kidney disease, more prevalent than autosomal dominant polycystic kidney disease (ADPKD). Awareness of this condition, particularly the autosomal recessive and autosomal dominant variants, has increased as genetic testing has become mainstream. What is Alport syndrome? Alport syndrome is a genetic condition with an abnormality of type

By |2024-09-25T15:38:04+00:00September 25th, 2024|Kidney Disease|0 Comments

Creatinine and Creatine – What’s the difference?

Creatine and creatinine sound similar, similar enough that patients may mistake them.  And then there’s creatinine kinase (CK) or creatinine phosphokinase (CPK).  If you’ve wondered what the difference is you're in luck - read on. Creatine Creatine is a molecule composed of 3 amino acids: glycine, arginine, and methionine. 90% of creatine is

By |2024-09-11T12:14:41+00:00September 11th, 2024|Dialysis, Kidney Disease|0 Comments

Use of Bisphosphonates and Denosumab in Kidney Disease

Bisphosphonates and denosumab are anti resorptive medications used for the treatment of: Osteoporosis Hypercalcemia, especially hypercalcemia of malignancy Hypercalcemia, Nephrology and the Milk Alkali Syndrome @BCNephro Hypercalcemia BCNephro Malignancy, particularly multiple myeloma and bone metastasis with solid tumors (prostate, breast, lung) Both classes of medications exert their anti resorptive effects by inhibiting osteoclast

By |2024-09-11T12:19:17+00:00September 4th, 2024|Kidney Disease|0 Comments

Renal Imaging – Nuclear Renal Scan

What is a Renal Scan? A nuclear medicine renal scan involves imaging with a compound taken up by the kidney that is bound to a radioisotope. There are different compounds used that are bound to the radioisotope technetium: MAG3: 99m dimercaptosuccinic acid Most common compound used for renal scans Rapid extraction by renal

By |2024-08-14T13:12:16+00:00August 14th, 2024|Kidney Disease|0 Comments

Dietary Protein and the Kidney

Is protein bad for the kidney?  Should protein be restricted?  Are there downsides to restricting protein? These questions will be addressed below. There are a wide range of recommendations for dietary protein intake for patients with Chronic Kidney Disease (CKD) and in general. Reasons Why High Protein May be Harmful in Kidney Disease

By |2024-08-01T00:27:46+00:00July 31st, 2024|Kidney Disease|0 Comments

MRI Contrast and the Kidney

Can MRI contrast be safely given to a patient with kidney disease? Iodinated contrast for CT or angiography is known to be associated with nephrotoxicity. Contrast Nephropathy does it exist? How to make it not happen | BCNephro Therefore it is reasonable to have concerns regarding MRI contrast. What is MRI Contrast? MRI

By |2024-07-17T12:20:20+00:00July 17th, 2024|Kidney Disease|0 Comments

Overview of Intravenous Fluids

Intravenous fluids (IVF) are frequently prescribed and comprise multiple formulations that may be hypotonic, isotonic or hypertonic to plasma.. To understand appropriate administration of IV fluids, an understanding of fluid distribution in the body is necessary. Overview of physiology of body fluid Total Body Water (TBW) Total body water is typically estimated as:

By |2024-07-10T15:03:11+00:00July 10th, 2024|Kidney Disease|0 Comments

Thrombotic Microangiopathy

  Thrombotic microangiopathy (TMA) comprises conditions that are of importance to nephrologists as they are: Associated with renal manifestations including acute kidney injury Frequently require treatment with plasmapheresis, a procedure which is often managed by the nephrologist Pathophysiology - What is it? A pathologic condition characterized by platelet microthrombi in the microvasculature.  This

By |2024-07-01T13:11:36+00:00July 1st, 2024|Kidney Disease, Uncategorized|0 Comments
Go to Top